Vienna, 2012.09.06 - On September 6th, 2012 LISAvienna received a delegation of entrepreneurs and scientists in the areas of nanotechnology and regenerative medicine during the international TERMIS-conference that took place in Vienna. The NanoRegen delegation was organized by the cell therapy and regenerative medicine expert Prof. Chris Mason from University College London as well as by Dr. Felicity Sartain, Programme Director & Theme Manager, Healthcare & Life Sciences at Nanotechnology KTN. During the event the participants presented their technologies and products and discussed the start-up funding possibilities in Austria and UK. Of particular interest to the British participants were the presentations of the two Austrian Life Science Entrepreneurs of British origin, Dr. Rod Hall (Mucokinetica) and Dr. Jason Slingsby (Protaffin). In the area of regenerative therapies Prof. Grillari (Evercyte) and Dr. Berger (TissueMedBiosciences) presented their respective companies. The event was supported by the British Embassy in Vienna.
Review: LISAvienna hosts UK Delegation Regenerative Medicine
The sender takes full responsibility for the content of this news item. Content may include forward-looking statements which, at the time they were made, were based on expectations of future events. Readers are cautioned not to rely on these forward-looking statements.
As a life sciences organization based in Vienna, would you like us to promote your news and events? If so, please send your contributions to news(at)lisavienna.at.